FTC's Amgen-Horizon Protest Raises Conglomerate Concerns
The Federal Trade Commission's recent complaint in the U.S. District Court for the Northern District of Illinois seeking to enjoin the closing of Amgen Inc.'s proposed $28 billion acquisition of Horizon Therapeutics...To view the full article, register now.
Already a subscriber? Click here to view full article